AstraZeneca resumes US COVID-19 vaccine trial. 5 points
The FDA has authorised the restart in the US, following the resumption of trials in other countries in recent weeks.
The clinical trials for the AstraZeneca Oxford coronavirus vaccine -- AZD1222 -- have resumed in the United States after approval by the Food and Drug Administration (FDA), the company said on Friday (local time).
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more